Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study
暂无分享,去创建一个
P. Greenland | M. Hoshen | R. Balicer | M. Avgil Tsadok | M. Leibowitz | O. Reges | M. Haim | A. Bachrach | H. Weinberg | Hana'a Rayyan-Assi
[1] A. Garg,et al. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] David W. Bates,et al. Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention , 2016, J. Am. Medical Informatics Assoc..
[3] J. Healey,et al. Identifying Patients With Atrial Fibrillation in Administrative Data. , 2016, The Canadian journal of cardiology.
[4] H. Bøtker,et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.
[5] Moshe Hoshen,et al. Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial Fibrillation , 2015, Journal of the American Heart Association.
[6] C. Murray,et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.
[7] J. Olgin,et al. Incident Atrial Fibrillation Among Asians, Hispanics, Blacks, and Whites , 2013, Circulation.
[8] D Kalra,et al. Electronic health records: new opportunities for clinical research , 2013, Journal of internal medicine.
[9] S. Brunak,et al. Mining electronic health records: towards better research applications and clinical care , 2012, Nature Reviews Genetics.
[10] K. Overvad,et al. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry , 2012, Scandinavian cardiovascular journal : SCJ.
[11] James Floyd,et al. A systematic review of validated methods for identifying atrial fibrillation using administrative data , 2012, Pharmacoepidemiology and drug safety.
[12] Elsayed Z Soliman,et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.
[13] Wansu Chen,et al. Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation , 2008, Stroke.
[14] Serguei V. S. Pakhomov,et al. Epidemiology of angina pectoris: role of natural language processing of the medical record. , 2007, American heart journal.
[15] B. Psaty,et al. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. , 2007, Archives of internal medicine.
[16] R. Cebul,et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation , 1996, Journal of General Internal Medicine.
[17] T. Lumley,et al. Risk of new-onset atrial fibrillation in relation to body mass index. , 2006, Archives of internal medicine.
[18] E. Ellerbeck,et al. Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients , 2004, Stroke.
[19] D. Berlowitz,et al. Identifying Hypertension-Related Comorbidities From Administrative Data: What's the Optimal Approach? , 2004, American journal of medical quality : the official journal of the American College of Medical Quality.
[20] S. Gaehde,et al. Anticoagulant Use for Atrial Fibrillation in the Elderly , 2004, Journal of the American Geriatrics Society.
[21] Yuchiao Chang,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.
[22] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[23] B. Griffith,et al. Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. , 2001, The Annals of thoracic surgery.
[24] I. Kronzon,et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation. , 2001, Circulation.
[25] D. Singer,et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. , 2000, Circulation.
[26] B. Gage,et al. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. , 1999, American heart journal.
[27] D. Einstadter,et al. Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries. , 1998, American journal of public health.
[28] H. Krumholz,et al. Warfarin use among patients with atrial fibrillation. , 1997, Stroke.
[29] L H Kuller,et al. Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.
[30] J. Whittle,et al. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? , 1997, Archives of internal medicine.